These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Guerreiro MM; Vigonius U; Pohlmann H; de Manreza ML; Fejerman N; Antoniuk SA; Moore A Epilepsy Res; 1997 Jun; 27(3):205-13. PubMed ID: 9237055 [TBL] [Abstract][Full Text] [Related]
8. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Bill PA; Vigonius U; Pohlmann H; Guerreiro CA; Kochen S; Saffer D; Moore A Epilepsy Res; 1997 Jun; 27(3):195-204. PubMed ID: 9237054 [TBL] [Abstract][Full Text] [Related]
9. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study]. Steinhoff BJ; Stefan H; Schulze-Bonhage A; Hueber R; Paulus W; Wangemann M; Elger CE Nervenarzt; 2012 Oct; 83(10):1292-9. PubMed ID: 22850688 [TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice. Pauletto G; Bergonzi P; Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel. Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896 [TBL] [Abstract][Full Text] [Related]
12. Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial. Kim JH; Lee SK; Loesch C; Namgoong K; Lee HW; Hong SB; Epilepsia; 2017 Apr; 58(4):e70-e74. PubMed ID: 28395124 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy. Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847 [TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world. Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487 [TBL] [Abstract][Full Text] [Related]
17. Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy. Franzoni E; Gentile V; Pellicciari A; Garone C; Iero L; Gualandi S; Cordelli DM; Cecconi I; Moscano FC; Marchiani V; Errani A J Neurol; 2009 Sep; 256(9):1527-32. PubMed ID: 19597919 [TBL] [Abstract][Full Text] [Related]
18. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726 [TBL] [Abstract][Full Text] [Related]
19. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953 [TBL] [Abstract][Full Text] [Related]
20. [Oxcarbazepine in the treatment of epilepsy]. Freidel M; Krause E; Kuhn K; Peper R; Vogel H Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]